NCT00951379 2016-04-06
Pioglitazone for Oral Premalignant Lesions
National Cancer Institute (NCI)
Phase 2 Terminated
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)